Konferenzservice Mandl

Zusammenfassung: The course will provide detailed information and the current state-of-the-art knowledge on “must know” topics such as writing SOP’s, the do’s and don’ts for the GLP audit, and Quality Assurance.

Ample time is allocated to each speaker in order to provide an interactive, in-depth tutorial with time for questions, detailed coverage of the subject and discussion of individual problems and situations. The audience will be strongly encouraged to interact, bring problems, discussion points or suggestions in order to brainstorm with the experts and share new information. You will be provided with printed handouts to follow along with the speakers and take notes.

Zusammenfassung: Welcome to the 3rd annual Stem Cells World Congress. This year's event will be held in beautiful Palm Springs, California - definitely the place to be in January! The conference will be co-located with the World Biobanking Summit. Registered delegates will have access to both meetings ensuring a very cost-effective trip. In addition, it will be immediately followed by LabAutomation 2009. Make the most of your trip by attending the co-located market analysis/business tutorial. Keynote Speakers: Bernard Siegel, Executive Director, Genetics Policy Institute Jan Nolta, Director Stem Cell Programme, University of California Agenda Topics to include: New Advances in Tissue Engineering New Horizons in Regenerative Medicine: Where will the Field be in 20 Years? Regulatory Issues Related to Stem Cell Therapies Stem Cells as Fundamental Tools for Drug Discovery and Disease-Related Research Therapeutic Advances Using Adult Somatic Stem Cells Therapeutic Potential of Pluripotent Human Embryonic and Reprogrammed Somatic Stem Cells

Zusammenfassung: Welcome to the inaugural World Biobanking Summit. This year's event will be held in beautiful Palm Springs, California - definitely the place to be in January! The conference will be co-located with the Stem Cells World Congress. Registered delegates will have access to both meetings ensuring a very cost-effective trip. In addition, it will be immediately followed by LabAutomation 2009. Agenda Topics to include: Sample Collection & Storage Automation Quality Assurance Bioethics & Regulations Harmonization & Standardization

Zusammenfassung: The three day forum (January 25-28, 2009 Baltimore, MD) will focus on the latest developments in Process Analytical Technology...emerging techniques, new applications, instrumentation, software, standards, and a look into the future.

Zusammenfassung: The 2009 Biomanufacturing Summit brings together world class leaders within biopharmaceuticals to explore the dynamic strategies, benchmark the latest technologies and analyze the most cutting edge science sustaining the growth of the biopharmaceutical industry.

Zusammenfassung: Developing a new drug and getting it to a successful marketing application is a very complex and multi-dimensional process. Even focusing on a single aspect of development – chemistry, manufacturing and controls—for example, requires an understanding of many highly specialized and complicated disciplines. Regulatory affairs personnel, working together with the development scientists, must see the “big picture” when it relates to the many individual development studies conducted. Thus, the Regulatory Affairs CMC professional must understand the issues faced in each scientific discipline and be able to evaluate the data generated with regard to its suitability for use in a regulatory submission.

Zusammenfassung: This program is designed both for people who are new to advertising and promotion issues, as well as those who have been involved in this area for some time. It is designed to provide a basic understanding of how the regulatory and legal environment has evolved and affects the marketing and promotion of pharmaceuticals. It also provides practical, day-to-day guidance on what can be learned from the latest FDA enforcement actions, and how companies can do their jobs better. This year’s program focuses on enforcement by the three centers within FDA that regulate drugs, biological products and veterinary drugs, direct-to-consumer advertising, state regulations, and the oversight of off-label issues by the Office of Inspector General and Department of Justice. The session also will explore the latest innovations in the use of the internet for product communication.

Zusammenfassung: Outsourcing Manufacturing of Biopharmaceuticals conference focuses on the specific needs of decision makers from sponsor companies and contract manufacturers to ensure you are making the best decisions for your organization regarding what to outsource, how to effectively control projects, how to assess the current CMO landscape, who to partner with, and most importantly how to ensure product safety and commercial success.

With an influx of outsourcing to emerging countries, this event provides the information you need to decide if it is right for your company, and addresses some of the tough questions surrounding safety, due diligence and risk in emerging countries.

Zusammenfassung: IBC's Process Validation for Biopharmaceuticals brings together process validation industry leading scientists, executives and quality assurance/regulatory experts and provides two full days of unique presentations, interactive panel discussions, conference track hopping and unprecedented networking opportunities. Case studies will offer real world examples of process validation activities implemented by industry leaders and help attendees analyze the latest industry trends including the influx in risk assessment and reduction.

Zusammenfassung: IBC's Antibody Development & Production continues to focus unwaveringly on the scientific, technical and strategic approaches to help accelerate process development while reducing cost and controlling quality. Exclusive case studies will deliver proven approaches to help improve manufacturability and optimize productivity during every critical stage of development. Industry experts will provide effective strategies to overcome the numerous manufacturing challenges faced by companies of all sizes and explore the alternatives to traditional purification processes. In addition, we will conduct several panel discussions, interactive workshops and strategy discussion groups that will provide invaluable and uncensored insight to help improve process development efforts in upstream and downstream processing.

Zusammenfassung: The 6th Anti-Infectives Partnering & Deal-Making Summit is a specialty conference for leading professionals in business development and infectious disease research. The Summit covers the industry's partnerships and alliances while providing a forum for new collaborations and information exchange. It also provides attendees with key insights on future deals as well as reports on new funding opportunities. Don't miss this unique forum!

Zusammenfassung: International Online Medical Conference (IOMC 2009) is the 2nd Online Conference on Medicine taking place on March 14 & 15, 2009. It aims to provide a forum for discussing and presenting research findings, studies, and experiences in the field of medicine, to create an opportunity for medical, nursing, and pharmaceutical/pharmacology researchers, students, professors, physicians, practitioners, researchers, executives, scientists, specialists and activists to meet each other online and share their research papers, and to provide a chance to find new research colleagues and partners for future research works.

Zusammenfassung: Your Next Blockbuster Is Only A Handshake At BioNetwork East 2009:

* Network With Top Decision Makers From Leading Pharmaceutical and Biotech Companies

* Find Specialty Pharmas With The Power To Increase Short And Long-Term Pipelines

* Gain A Sneak Peek Into University-Stage Products Not Yet In The Public Eye

* Form Proactive Alliance Management Tactics For Dealing With Partners In Japan, India And Canada

* Navigate The Changing World Of Regulations, Deal Structures And Contract Legalese

Zusammenfassung: Digging Into the Deals. Windhover's must-attend event is a Strategic Level Conference On Biopharma Deal Structure and Strategy

Zusammenfassung: BIO-Windhover continues to be the preferred US-based partnering event for top-level pharmaceutical and biotechnology business development executives and CEOs. At this exclusive conference, attendees will be able to meet one-on-one with other key decision-makers and network with their peers for a more personal experience in an upscale setting.

Zusammenfassung: Drug discovery is an expensive and challenging process. In silico methods have played a key role in aiding the discovery process, in pharmaceutical companies and government institutes alike. Government initiatives (Molecular Library Initiative and Chemical Genetics Initiative) have lead to an increase in the amount of available public data in the form of chemical compounds, and experiments analyzing the interaction of compounds with proteins/genes i.e., biological spaces. www.cs.gmu.edu/~hrangwal/rxdm

Zusammenfassung: Welcome to the Nucleic Acid Diagnostics & Therapeutics Summit. This inaugural summit will be be held in Boston, MA immediately prior to the annual RNAi World Congress, which will address the latest research in RNAi and microRNA research. In contrast the DxRx Summit will be attended by investors, corporate management, business leaders, legal & regulatory advisors, clinical trial CROs and others who are interested in the diagnostic and therapeutic applications of DNA, RNAi, microRNAs, and antisense technology. Registered delegates will also be eligible to attend a half-day interactive business tutorial on the market and business landscape for diagnostics and therapeutics based on RNAi and microRNAs hosted by Enal Razvi, PhD. Agenda Topics to include: Reviews of Company Pipelines Clinical Trial Status of Nucleic Acid-Based Therapeutics Patent Status of Nucleic Acid-Based Diagnostics and Therapeutics Nucleic Acid Drug Delivery microRNAs as Diagnostics and Therapeutic Entities Nucleic Acid Biomarkers for Personalized Medicine Reimbursement and Regulatory Landscape Investor Attitudes to this Sector Emerging Company Showcase Confirmed Speakers: Dr Patrick Y. Lu, President and CEO, Sirnaomics Dr Dmitry Samarsky, VP Technology Development, RXi Pharmaceuticals Dr James Hamilton, CEO, Calando Pharmaceuticals Prof James G Patton, Vanderbilt University Jeffery Vick, CEO, Silence Therapeutics Dr Nobuyoshi Kosaka, National Cancer Center Research Institute, Tokyo Dr Nicolay Ferrari, Director of Pharmacology, Topigen Dr Søren Tulstrup, CEO, Santaris Pharma Dr William Marshall, President and CEO, Miragen Therapeutics

Zusammenfassung: The Convergence Forum is an annual event created by life sciences leaders, for life sciences leaders. A select group of 125 participants will gather In Newport, RI on June 11 - 13 to explore the forces shaping the future of biotech, pharma, venture capital, healthcare, and medical devices.

Zusammenfassung: The 58th Natural Products Gordon Research Conference will continue a tradition of excellence in a broad range of areas relating to natural products chemistry and isolation, novel synthetic methods, chemical biology, bioorganic and medicinal chemistry. While remaining true to its foundation of organic synthesis of natural products, the speakers in this years' outstanding lineup will deliver lectures in topics as diverse as catalytic synthetic methodology, the use of natural product like molecules as tools to probe and better understand biological systems, and recent advances in drug discovery.

Zusammenfassung: Welcome to the Target Discovery World Congress, combining our successful Screening and Ion Channel Targets conferences. This year's event will take place at the South San Francisco Conference Center. Keynote Speaker Jeffery Conn Lee E. Limbird Professor of Pharmacology Director, Vanderbilt Program in Drug Discovery Agenda Topics Target Identification and Validation Ion Channel Targets G-Protein Coupled Receptors Protein Kinase Targets Ubiquitin Targets Nuclear Receptor Targets Cell-Based Assays High Content Analysis

Zusammenfassung: Welcome to the Lab-on-a-Chip World Congress, designed to review existing and new life science applications of microfluidic technologies. This year's event will take place at the South San Francisco Conference Center. The conference will be co-located with the Microarray World Congress and Molecular Diagnostics World Congress. Registered delegates will also have access to these meetings ensuring a very cost-effective trip. Keynote Speaker Holger Becker, Director, Microfluidic ChipShop Agenda Topics Point-of-care diagnostics Microfabrication/engineering Life science applications

Zusammenfassung: The conference will be co-located with the Lab-on-a-Chip World Congress and Molecular Diagnostics World Congress. Registered delegates will also have access to these meetings ensuring a very cost-effective trip.

Zusammenfassung: The conference will be co-located with the Microarray World Congress and Lab-on-a-Chip World Congress. Registered delegates will also have access to these meetings ensuring a very cost-effective trip.

Zusammenfassung: This symposium, hosted by EORTC, NCI and AACR, will bring together academics and scientists and representatives from the pharmaceutical industry to discuss innovation in drug development, target selection and the impact of new discoveries in molecular and cell biology. Understanding the pathways and mechanisms which cause cancer and regulate the biological behavior of tumor cells has lead to the development of numerous new agents and innovative targets for clinical trials. This conference has been organized to reflect the many recent advances in the early development of promising new compounds, which are in different levels of preclinical and clinical development. It will bring together delegates from all over the world igniting a huge exchange of information and promoting and developing global partnerships in translational research. Please mark your calendars for this exciting program and bookmark this page for additional information.